Viloxazine
Back to searchMolecule Structure
Scientific Name
Viloxazine
Description of the Drug
Viloxazine is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults in children.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09185
http://www.drugbank.ca/drugs/DB09185
Brand Name(s)
Not Available
Company Owner(s)
Supernus Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34168 | |
Human Metabolome Database | HMDB0259807 | |
DrugBank | DB09185 | |
PubChem: Thomson Pharma | 14798292 | |
PubChem | 5666 | |
LINCS | LSM-5092 | |
Nikkaji | J16.881E | |
BindingDB | 50025691 | |
EPA CompTox Dashboard | DTXSID6057900 | |
DrugCentral | 2820 | |
ChemicalBook | CB0911793 | |
rxnorm | VILOXAZINE HYDROCHLORIDE | VILOXAZINE |
ChEBI | 94405 |